Read our New Blog Post  -  The Multitude of Glycoforms

Our Products

Most ovarian cancer cases are diagnosed when the disease is advanced.
ONLY 15% of cases are diagnosed in the early stages.

Cancer Liquid Biopsy

Blood Test for Ovarian Cancer Diagnosis
Most ovarian cancer cases are diagnosed when the disease is advanced.
ONLY 15% of cases are diagnosed in the early stages.

Ovarian cancer causes more deaths than any other cancer of the female reproductive system, but it accounts for only about 3% of all cancers in women. Early and accurate diagnosis of ovarian cancer will improve survival, as treatment works best when cancer is detected in its early stages.

InterVenn is developing a first-in-class mass spec-based glycoproteomic clinical diagnostic test for ovarian cancer. Currently undergoing clinical validation in a global, multi-center clinical trial, this proprietary test will enable clinicians to distinguish benign from malignant masses in women presenting with adnexal (pelvic) masses, through a simple blood test.

Learn more about participating in the VOCAL trial at ClinicalTrials.gov (NCT03837327).

Hey! Just letting you know we use cookies. We use cookies to improve your browsing experience. By continuing to browse this site, you agree to our privacy policy and use of cookies.